Skip to content

Clinical trials

Phase 3 Polycythemia Vera trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Polycythemia Vera Phase: Phase 3 Country / region: United Kingdom Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20111
20121
20131
20141
20191
20221
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting4
Completed3
Terminated2
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
CTI BioPharma2
Incyte Corporation2
Italfarmaco1
Merck Sharp & Dohme LLC1
Ono Pharmaceutical Co., Ltd.1
Protagonist Therapeutics, Inc.1
Ronald Hoffman1
University of Birmingham1
University of Glasgow1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Polycythemia Vera11
Thrombocythemia, Essential5
Primary Myelofibrosis4
Myeloproliferative Disorders3
Anemia2
Bone Marrow Diseases2
Hematologic Diseases2
Splenomegaly2
Thrombocytopenia2
Anxiety Disorders1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.